Summary:
Approximately three-year program with only 12 office visits. Study medications are all FDA approved.
Qualified Participants Must:
• Have osteoarthritis of hand, hip and/or knee
• Require some form of medication for arthritis at least half of the time within the past 6 months
• Have cardiovascular disease or risks factors for CV disease.
Qualified Participants May Receive:
Study-related medication (no placebo) and medical care, and compensation of $50 per visit.